XSpray Pharma AB (OSTO:XSPRAY) Beginning Cash Position : kr208.24 Mil (As of Mar. 2025)

View and export this data going back to 2017. Start your Free Trial

What is XSpray Pharma AB Beginning Cash Position?

XSpray Pharma AB's Beginning Cash Position for the quarter that ended in Mar. 2025 was kr208.24 Mil.

XSpray Pharma AB's quarterly Beginning Cash Position declined from Sep. 2024 (kr126.57 Mil) to Dec. 2024 (kr74.76 Mil) but then increased from Dec. 2024 (kr74.76 Mil) to Mar. 2025 (kr208.24 Mil).

XSpray Pharma AB's annual Beginning Cash Position declined from Dec. 2022 (kr271.88 Mil) to Dec. 2023 (kr120.17 Mil) but then increased from Dec. 2023 (kr120.17 Mil) to Dec. 2024 (kr166.30 Mil).

XSpray Pharma AB Beginning Cash Position Historical Data

The historical data trend for XSpray Pharma AB's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

XSpray Pharma AB Beginning Cash Position Chart

XSpray Pharma AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Beginning Cash Position

Get a 7-Day Free Trial

209.87

325.60

271.88

120.17

166.30

XSpray Pharma AB Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Beginning Cash Position	Get a 7-Day Free Trial															166.30	104.16	126.57	74.76	208.24

XSpray Pharma AB Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

XSpray Pharma AB Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of XSpray Pharma AB's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

XSpray Pharma AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » XSpray Pharma AB (OSTO:XSPRAY) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

0GHZ:UK 6XP:Germany

Address

Scheeles vag 2, Solna, SWE, SE-171 65

Website

https://www.xspraypharma.com

XSpray Pharma AB is a pharmaceutical company focused on developing improved PKIs for cancer treatment, leveraging its proprietary HyNap technology platform. The company aims to enhance clinical outcomes for cancer patients by improving the efficacy, safety, and patient experience of existing cancer therapies. Its product portfolio includes Dasynoc and other product candidates in different stages of development such as XS003 nilotinib, XS008 axitinib, and other.

XSpray Pharma AB Headlines

No Headlines